AEHL Q3 2012 Earnings EPS Beats Estimates by 768 Amid Steep Stock Decline Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus AMBP Q1 2026 Earnings Strong EPS Beat Overshadowed by Market Headwinds RWTN Q1 2026 Earnings EPS Falls Short of Estimates but Shares Edge Higher Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn NRT Q2 2025 Earnings Trust Reports EPS of 020 Shares Gain 064